- Home
- TIRX vs ATHA Comparison
TIRX vs ATHA Comparison
Compare TIRX & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIRX
- ATHA
- Stock Information
- Founded
- TIRX 2010
- ATHA 2011
- Country
- TIRX China
- ATHA United States
- Employees
- TIRX N/A
- ATHA N/A
- Industry
- TIRX Specialty Insurers
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- TIRX Finance
- ATHA Health Care
- Exchange
- TIRX Nasdaq
- ATHA Nasdaq
- Market Cap
- TIRX 12.0M
- ATHA 10.6M
- IPO Year
- TIRX 2021
- ATHA 2020
- Fundamental
- Price
- TIRX $1.15
- ATHA $0.41
- Analyst Decision
- TIRX
- ATHA Buy
- Analyst Count
- TIRX 0
- ATHA 4
- Target Price
- TIRX N/A
- ATHA $11.25
- AVG Volume (30 Days)
- TIRX 68.6K
- ATHA 244.1K
- Earning Date
- TIRX 08-15-2025
- ATHA 07-31-2025
- Dividend Yield
- TIRX N/A
- ATHA N/A
- EPS Growth
- TIRX N/A
- ATHA N/A
- EPS
- TIRX N/A
- ATHA N/A
- Revenue
- TIRX $3,219,336.00
- ATHA N/A
- Revenue This Year
- TIRX N/A
- ATHA N/A
- Revenue Next Year
- TIRX N/A
- ATHA N/A
- P/E Ratio
- TIRX N/A
- ATHA N/A
- Revenue Growth
- TIRX 158.74
- ATHA N/A
- 52 Week Low
- TIRX $1.07
- ATHA $0.22
- 52 Week High
- TIRX $4.15
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- TIRX 37.55
- ATHA 64.39
- Support Level
- TIRX $1.11
- ATHA $0.37
- Resistance Level
- TIRX $1.18
- ATHA $0.46
- Average True Range (ATR)
- TIRX 0.07
- ATHA 0.04
- MACD
- TIRX 0.00
- ATHA 0.00
- Stochastic Oscillator
- TIRX 8.57
- ATHA 64.99
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.